FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - THERAFECTIN - ROLE OF ARTHRITIS ADVISORY-COMMITTEE IN FDA REVIEW PROCESS - PERSONNEL CHANGES - ISSUES OF OVER-THE-COUNTER SWITCHING

被引：0

|

作者：

FURST, DE ^{[1
]}

PAULUS, HE ^{[1
]}

机构：

[1] VIRGINIA MASON RES CTR,CLIN RES PROGRAMS,SEATTLE,WA 98101

来源：

ARTHRITIS AND RHEUMATISM | 1994年 / 37卷 / 09期

关键词：

D O I：

10.1002/art.1780370921

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：1408 / 1409

页数：2

相关论文

共 26 条

[1] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING
PAULUS, HE
ARTHRITIS AND RHEUMATISM, 1982, 25 (09): : 1124 - 1125
[2] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING
PAULUS, HE
ARTHRITIS AND RHEUMATISM, 1982, 25 (05): : 595 - 596
[3] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING
PAULUS, HE
ARTHRITIS AND RHEUMATISM, 1983, 26 (10): : 1288 - 1289
[4] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING
PAULUS, HE
ARTHRITIS AND RHEUMATISM, 1985, 28 (04): : 450 - 451
[5] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - CHANGES IN THE REVIEW PROCESS FOR ANTIARTHRITIS DRUGS - LABELING OF ANALGESICS
PAULUS, HE
ARTHRITIS AND RHEUMATISM, 1989, 32 (10): : 1328 - 1329
[6] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - EXPANDED ROLE FOR COMMITTEE MEMBERS - GUIDELINES ON ANALGESICS
PAULUS, HE
ARTHRITIS AND RHEUMATISM, 1991, 34 (12): : 1619 - 1619
[7] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - JUVENILE RHEUMATOID-ARTHRITIS DRUG-EVALUATION GUIDELINES - OVER-THE-COUNTER NAPROXEN
PAULUS, HE
ARTHRITIS AND RHEUMATISM, 1994, 37 (01): : 137 - 138
[8] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - POSTMARKETING SURVEILLANCE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS
PAULUS, HE
ARTHRITIS AND RHEUMATISM, 1985, 28 (10): : 1168 - 1169
[9] SELECTION OF FDA ADVISORY-COMMITTEE MEMBERS
PODELL, LB
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1983, 40 (10): : 1614 - 1614
[10] FDA ADVISORY-COMMITTEE SYSTEM EVALUATED
不详
LANCET, 1993, 341 (8836): : 45 - 45